期刊文献+

局部注射博莱霉素诱导小鼠硬皮病模型 被引量:6

Mouse model of sclerotic skin induced by local injections of bleomycin
下载PDF
导出
摘要 目的 建立小鼠硬皮病动物模型。方法 将 0 .0 1~ 1mg博莱霉素皮下注射于 6周龄BALB/c雌性小鼠背部皮肤 ,第日 1次共注射 4周。取注射区皮肤行光镜和电镜观察 ,并用免疫组化方法检测TGFβ1、TGFβ2 和α SMA的表达。结果  0 .1mg/d以上博莱霉素剂量在 4周后皆可致小鼠背部皮肤硬化 ,表现为皮肤弹性降低、毛发脱落、表皮萎缩、真皮炎细胞浸润、毛囊减少或消失、纤维组织增生、大量肌成纤维细胞增生 ,真皮TGFβ1、TGFβ2 和α SMA表达增强。结论 博莱霉素连续皮下注射可导致小鼠皮肤硬化 ,符合硬皮病皮肤基本的组织病理学改变。 Objective To establish animal model for scleroderma.Methods Bleomycin was subcutaneously injected into the shaved back skin of female BALB/c mice aged 6 weeks at a dosage of 0.01mg-1mg per day for 4 weeks. The skin change was observed by light and transmission electron microscopy. The expression of TGFβ 1 and a-sma TGFβ 2,was investigated by immunohistochemical staining. Results More than 0.1mg/d of bleomycin could induce dermal sclerosis on mice back skin after 4 weeks. Sclerotic skin with reduced elasticity and hairloss exhibited atrophy of epidermis, inflammatory infiltration in dermis, reduction or disappearance of hair follicles, fibroproliferation with a large number of myofibroblasts, and increased expression of TGFβ 1,TGFβ 2 and a-sma. Conclusion A mouse model for scleroderma can be successfully established in BALB/c mice after 4-week injection of bleomycin.
出处 《重庆医学》 CAS CSCD 2004年第12期1821-1823,1825,共4页 Chongqing medicine
基金 国家自然科学基金课题 (30 1 0 0 1 62 )
关键词 博莱霉素 硬皮病 动物模型 bleomycin scleroderma animal model
  • 相关文献

参考文献9

  • 1Nguyen VA, Sgonc R, Dietrich H,et al. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma)[J].J Autoimmun,2000,14(2):143
  • 2Czuwara-Ladykowska J, Gore EA, Shegogue DA,et al. Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts[J].Br J Dermatol,2001,145(4):569
  • 3Pannu J, Gore-Hyer E, Yamanaka M,et al.An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta rec
  • 4Yamamoto T, Nishioka K. Role of monocyte chemoattractant protein-1 and its receptor,CCR-2, in the pathogenesis of bleomycin-induced scleroderma[J].J Invest Dermatol,2003,121(3):510
  • 5Marie I, Beny JL. Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1[J].J Invest Dermatol,2002,119(6):1379
  • 6Kubo M, Ihn H, Yamane K,et al.Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis[J].J Rheumatol,2002,29(12):2558
  • 7Zhang Y, Gilliam AC. Animal models for scleroderma: an update[J].Curr Rheumatol Rep,2002,4(2):150
  • 8Sambo P, Jannino L, Candela M,et al. Monocytes of patients wiht systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion[J].J Invest Dermatol,1999,112(1):78
  • 9Yamamoto T,Takahashi Y, Takagawa S,et al.Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice[J]. J Rheumatol,1999,26(12): 2628

同被引文献69

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部